MN-001 (tipelukast) is a Medicinova Inc program. Its next catalyst is a Readout in Dec 2026.
All upcoming FDA decision dates on the 2026 PDUFA calendar
Sponsor: Medicinova Inc (MNOV). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.
The next tracked catalyst for MN-001 (tipelukast) is a Readout in Dec 2026.
No FDA decision for MN-001 (tipelukast) is in our archive yet.
Medicinova Inc (MNOV).
FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.